Company: CLX
Filing Date: 2025-10-07
Form Type: DEF 14A
Source: 0001552781-25-000311
Chunk: 60

Company: CLOROX CO /DE/
Filing Date: 2025-10-07
Form: DEF 14A
Chunk 60
---
5, compared to                                
 $695 in fiscal year 2024. Free cash flow was $761 or 10.7% of net sales in fiscal year 2025,                       
 compared to $483 or 6.8% of net sales in fiscal year 2024 (refer to the reconciliation of                          
 net cash provided by operations to free cash flow in “Financial Position and Liquidity—Investing—Free Cash Flow”). |

| • | The                                                                                                          
 Company paid $602 in cash dividends to stockholders in fiscal year 2025, compared to $595                    
 in cash dividends paid in                                                                                    
 fiscal year 2024. In July 2025, the Company announced an increase of 2% in its dividend from the prior year. |

| The                                              
 Clorox Company 2025 Proxy Statement > Appendix A | A-3 |

Strategic Goals and Initiatives

The Company’s IGNITE strategy—underpinned by its purpose and enduring values—accelerates innovation in key areas of the business to drive growth and deliver value for all Clorox stakeholders. IGNITE focuses on four strategic choices aimed at fueling long-term growth; innovating consumer experiences; reimagining how the company and its people work; and continuously evolving the product portfolio. The Company’s long- term financial goals reflected in IGNITE include annual net sales growth of 3% to 5%—increased from 2% to 4% in 2021—annual adjusted EBIT margin expansion of 25 to 50 basis points and annual free cash flow as a percentage of net sales of 11% to 13%.

In September 2024, the Company completed the divestiture of its Better Health VMS business, which included the Natural Vitality, NeoCell, Rainbow Light and RenewLife brands, relevant trademarks and licenses, and associated manufacturing and distribution facilities in Sunrise, Florida. The transaction was in support of the Company’s IGNITE strategy and the commitment to evolve its portfolio to increase focus on its core business to drive more consistent, profitable growth.

In February 2025, the Company announced that the Venture Agreement with The Procter & Gamble Company (P&G) for the Company’s Glad bags and wraps business will wind down by January 31, 2026. The Company will acquire P&G’s 20% interest in the venture for cash at fair value as established by predetermined contractual valuation procedures.

As announced in August 2021, the Company continues to invest in transformative